In the latest trading session, Astrazeneca (AZN) closed at $72.66, marking a -1.38% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 0.4%. Elsewhere, the Dow ...

On July 22, 2025, famed heavy metal singer Ozzy Osbourne died at age 76. Although his family did not release a cause of death ...

The trial will test several treatment approaches in the maintenance setting for extensive stage small cell lung cancer.

Akero Therapeutics Inc. (NASDAQ: AKRO) is one of the best mid cap pharma stocks to buy. On July 16, AstraZeneca announced ...

The inhaler, with an older propellant, is already approved in Europe for the treatment of adults with chronic obstructive ...

This week's episode covers news about Sarepta, babies born following mitochondrial transfer, and AI identifying therapy ...

In this article, you’ll find some of the top content that was published on LCGC this week, including an ASMS 2025 retrospective and an overview of microplastic research.

AstraZeneca's shares are up 3.5% over the year to date but remain down 11% over the past 52 weeks.

Bristol Myers Squibb's chief medical officer, Samit Hirawat, is leaving the drugmaker to pursue new professional opportunities.

With 1 August fast approaching, we expect the Trump administration to announce pharmaceutical tariffs soon. We anticipate an ...

Dispatch Bio launched with $216 million – backed primarily by Parker Institute for Cancer Immunotherapy, founded by entrepreneur Sean Parker, and ARCH Venture Partners. SAB BIO announced an ...